On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Outline
- Genomic disorders
- Nonallelic homologous recombination
- Range of genomic variation
- Key genomic disorders discovered before 2004
- Genomic heteromorphisms
- Cytogenetic detection of structural variants
- Gene deletion/duplication syndromes prior to 2004
- Current CNV repository data
- Array-based methods for CNV discovery
- Genome-wide methods for CNV discovery
- Methods of CNV detection (1)
- Multiplex PCR-based methods for CNV detection
- Methods for CNV detection (2)
- Determination of clinical relevance
- Criteria for designation - location and confirmation
- Criteria for designation - novel CNV
- Criteria for designation - combinations of CNVs
- Risk assessment of a CNV with family data
- Risk assessment of a novel CNV (1)
- Case study - DiGeorge syndrome
- Case study - DiGeorge syndrome - qPCR array
- Findings from this case study
- Williams-Beuren syndrome (WBS) qPCR array
- WBS region
- FISH analysis of duplication
- Expression of genes within the WBS region
- Differences between WBS deletion and duplication
- Microsatellite analysis of family members
- Risk assessment of de novo 7q11.23 duplication
- 7q11.23 duplication conclusions
- Another novel CNV - GJA5 deletion
- GJA5 quantitation
- 1q21.1 deletion
- 1q21.1 deletion CNV cases
- Clinical findings for 1q21.1 CNV cases
- Cardiac and cytogenetic analysis of del1q21.1
- Summary of del1q21.1 case totals
- 1q21 critical region genes
- Congenital cataracts
- Risk assessment of a novel CNV (2)
- 1q21.1 deletion / duplication conclusions
- Comprehensive analysis of del1q21.1
- Analysis of dup1q21.1
- Pedigrees of 1q21.1 deletion probands
- Array CGH analysis
- Del1q21.1 conclusions
- CNVs in diagnostics
- CNVs and disease
- CNVs and predictive testing
- Acknowledgements
Topics Covered
- Copy number variants, and the history of genomic rearrangements and disease
- Methods used for copy number variant detection
- Criteria to determine whether or not a copy number variant is associated with disease
- Application of these criteria in molecular diagnostics, with examples of novel copy number variants
Talk Citation
Somerville, M. (2009, August 30). Quantitative CNV testing in molecular diagnostics [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/TRZU3116.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Martin Somerville has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.